Ambev S.A. ABEV
2.65 USD -0.04 (-1.67%)
At closeNov 3, 2026, 4:00 PM EST
2.64 0.00 -0.19%
After hours · Nov 3, 4:00 PM ET
2.62 Day range 2.67
2.28 52-week range 3.45
- YTD
- +7.09%
- 1 year
- +12.55%
Analyst view
Consensus: hold
Hold
Price target (mean) 3.20 +20.8% upside
Now 2.65
- Target (low)
- 2.64
- Target (mean)
- 3.20
- Target (high)
- 4.00
Ratings (0m) 11 3 buy · 5 hold · 3 sell
- Strong buy2
- Buy1
- Hold5
- Sell2
- Strong sell1
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.0605 | 0.05798 – 0.063 | 0.05398 | +12.1% | 25.70B | +3.6% | 4 |
| Next quarter | 0.05 | 0.05 – 0.05 | 0.04841 | +3.3% | 23.22B | +3.4% | 1 |
| Current year | 0.19866 | 0.196 – 0.20277 | 0.17929 | +10.8% | 90.69B | +2.8% | 7 |
| Next year | 0.20866 | 0.18781 – 0.22 | 0.19866 | +5.0% | 95.12B | +4.9% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 7, 2026 | B of A Securities | Downgrade | Neutral | Underperform |
| Jul 15, 2026 | Scotiabank | Downgrade | Sector Outperform | Sector Perform |
| May 14, 2026 | UBS | Maintained | Sell | Sell |
| May 6, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 16, 2026 | UBS | Downgrade | Neutral | Sell |
| Feb 17, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 26, 2025 | Bernstein | Downgrade | Outperform | Market Perform |
| Aug 20, 2025 | UBS | Maintained | Neutral | Neutral |
| Aug 1, 2025 | HSBC | Downgrade | Buy | Hold |
| Jun 4, 2025 | UBS | Maintained | Neutral | Neutral |
| May 12, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 22, 2025 | UBS | Downgrade | Buy | Neutral |
| Apr 7, 2025 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Mar 5, 2025 | UBS | Maintained | Buy | Buy |
| Jan 22, 2025 | Citigroup | Downgrade | Buy | Neutral |
| Jan 21, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2024 | UBS | Maintained | Buy | Buy |
| May 9, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Mar 4, 2024 | Barclays | Downgrade | Overweight | Equal-Weight |
| Nov 22, 2023 | Jefferies | Initiated | — | Hold |
| May 24, 2023 | Bernstein | Initiated | — | Outperform |
| Jul 13, 2022 | JP Morgan | Upgrade | Neutral | Overweight |
| Nov 3, 2021 | B of A Securities | Upgrade | Underperform | Neutral |
| Oct 6, 2021 | Barclays | Upgrade | Equal-Weight | Overweight |
| Jun 17, 2021 | Barclays | Upgrade | Underweight | Equal-Weight |
| May 20, 2021 | Itau BBA | Downgrade | Outperform | Market Perform |
| Jan 13, 2021 | Bradesco | Downgrade | Neutral | Underperform |
| Nov 3, 2020 | Citigroup | Upgrade | Neutral | Buy |
| Mar 24, 2020 | JP Morgan | Downgrade | Neutral | Underweight |
